Adia Med Q3 2026 Results: Net Loss of $53K
Adia Med, Inc. reported total revenue of $1,019,245 for the nine months ended September 30, 2026, a significant increase from $521,958 in the prior year, driven primarily by medical procedures and biologics sales. Despite the revenue growth, the company realized a net loss of $271,922 for the period as operating expenses, particularly legal and professional fees and salaries, increased substantially.
- Key figure
- Net loss $53K